This is fully supported by our meta-analysis on the risk of hypoglycaemia on the studies and the subgroup (Additional file2: Table S3) examined, in which the risk of hypoglycaemia was significantly reduced compared with control (P < 0.00001) between studies that used an insulin infusion protocol. The gene discussed is INS; the disease is Hypoglycemia.